Blood tests for asbestos-related mesothelioma

March 9, 2007

Oncology. 2006;71(1-2):26-31. Epub 2007 Mar 5. [Link]

Maeda M, Hino O.

Immuno-Biological Laboratories Co., Ltd., Fujioka-Shi, Japan.

Abstract

Mesothelioma is an aggressive tumor arising from the mesothelium, and is usually associated with previous exposure to asbestos. The incubation period of the tumor may be described as 30-40 years, and the prognosis is dismal. Recently, serum markers for the diagnosis of mesothelioma have been reported as candidates. In this paper, we mini-reviewed the potential utility of ELISA systems as serum diagnostic markers for asbestos-related mesothelioma.

Posted in Diagnosis & Differentiation, Full Archive, General, Serum Marker/Blood Test, Type of Assessment: